What are the absolute contraindications to thrombolysis in this patient with acute ischemic stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Absolute Contraindications to Thrombolysis in Acute Ischemic Stroke

Low platelet count, history of stroke, and elevated blood pressure are the absolute contraindications to thrombolysis in this patient with acute ischemic stroke.

Analysis of Patient's Contraindications

This 78-year-old female presents with symptoms of acute ischemic stroke with a large vessel occlusion in the middle cerebral artery. When evaluating eligibility for thrombolysis, several factors must be considered:

Absolute Contraindications Present:

  1. Low Platelet Count (<100,000/mm³)

    • The patient's platelet count is 98,000/mm³, which falls below the threshold of 100,000/mm³
    • This is an absolute contraindication according to current guidelines 1
  2. Recent Stroke (within past 3 months)

    • The patient had a stroke 2 months ago with residual right-sided deficits
    • Guidelines clearly state that stroke within the previous 3 months is an absolute contraindication 2
  3. Elevated Blood Pressure (>185/110 mmHg)

    • The patient's blood pressure is 194/107 mmHg
    • Blood pressure exceeding 185/110 mmHg is an absolute contraindication unless it can be safely reduced 2, 1

Other Factors That Are NOT Absolute Contraindications:

  1. Dabigatran Use

    • While the patient was on dabigatran, it was stopped 4 days ago
    • With an INR of 1.2 and normal coagulation studies, this is not an absolute contraindication
    • The effects of dabigatran typically resolve within 48-72 hours in patients with normal renal function 3
  2. Advanced Age

    • Age >80 years alone is no longer considered a contraindication to thrombolysis 4
    • Studies have shown benefit of thrombolysis in elderly patients with an adjusted odds ratio of 1.40 (95% CI, 1.14-1.70) 4
  3. Breast Cancer History

    • Past history of breast cancer status post mastectomy is not listed as an absolute contraindication in any guidelines
    • Only active internal bleeding or known bleeding diathesis would be contraindications 2
  4. Time Window

    • The patient's symptoms began approximately 3 hours before presentation
    • This falls within the 4.5-hour treatment window for IV thrombolysis 1
  5. Large Vessel Occlusion

    • The presence of a large vessel occlusion is not a contraindication to thrombolysis
    • In fact, guidelines recommend IV thrombolysis prior to mechanical thrombectomy in eligible patients 1

Clinical Decision Algorithm

  1. Evaluate absolute contraindications:

    • Platelet count <100,000/mm³? Yes → Contraindication
    • Stroke within past 3 months? Yes → Contraindication
    • BP >185/110 mmHg? Yes → Contraindication (unless rapidly controlled)
  2. Consider relative contraindications:

    • Recent anticoagulant use? No (stopped 4 days ago with normal INR)
    • Advanced age? Not a contraindication
    • Cancer history? Not a contraindication for thrombolysis

Conclusion

The patient has three absolute contraindications to thrombolysis: low platelet count, recent stroke within the past 3 months, and elevated blood pressure. While the elevated blood pressure might potentially be treated to bring it within acceptable range, the other two contraindications cannot be modified. The combination of these factors significantly increases the risk of symptomatic intracranial hemorrhage following thrombolysis 5, making the patient ineligible for this treatment.

References

Guideline

Acute Ischemic Stroke Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014

Related Questions

What are the absolute contraindications for stroke thrombolysis with intravenous tissue plasminogen activator (tPA)?
What is the management for a patient presenting with ischemic stroke within 2 hours, with a CT scan showing left sided main carotid artery and middle cerebral artery (MCA) involvement?
What is the management for an elderly man presenting 2 hours after onset of symptoms with a non-hemorrhagic stroke, with a history of non-hemorrhagic stroke 2 months ago, and a CT scan confirming non-hemorrhagic stroke?
What are the contraindications for thrombolysis?
What is the most appropriate therapy for an 81-year-old male with acute ischemic stroke due to M1 middle cerebral artery (MCA) occlusion, with a National Institutes of Health Stroke Scale (NIHSS) score of 15, who is eligible for thrombectomy?
At what age does the anterior fontanelle typically close?
What is the most appropriate agent for urgent reversal of anticoagulation with apixaban (factor Xa inhibitor) in a critically ill patient requiring immediate surgery?
Is colangite defined as inflammation of the bile ducts, infection of the bile ducts, or both?
What is the next step for a middle-aged lady with a breast cyst that did not completely resolve after needle (percutaneous) aspiration?
Is it recommended to use Lokelma (sodium zirconium cyclosilicate) and Kayexalate (sodium polystyrene sulfonate) together for the treatment of hyperkalemia?
What intervention should be added to the treatment regimen for a patient with severe hypotension, bradycardia, and refractory shock due to beta-blocker (metoprolol succinate) overdose?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.